New IDSA guidelines to treat drug resistant gram-negative bacteria

Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections.  The GameChangerThe new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.Guests Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthAmanda Bushman, PharmD, BCPS-AQ ID, BCIDP, FIDSAInfectious Disease PharmacistUnityPoint HealthTony Mannum, PharmDPGY2 Infectious Disease ResidentUnityPoint HealthReferenceIDSA Guidelines for treating resistant gram negative organisms Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.0.05 CEU/0.5 HrUAN:  0107-0000-24-251-H01-PInitial release date: 09/02/2024Expiration date: 09/02/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram